FREQUENCY OF OSTEOPOROSIS IN CHRONIC LIVER DISEASE PATIENTS

K KOUR; MI KHAN; J SAJJAD; MA KHAN; N RIAZ; IH ANJUM

doi:10.54112/bcsrj.v2024i1.1469

Authors

K KOUR Department of Medical Ward, Mardan Medical Complex Mardan, Pakistan
MI KHAN Department of Dermatology, Combined Military Hospital Peshawar, Pakistan
J SAJJAD Department of General Medicine, Aziz Bhatti Shaheed Teaching Hospital Gujrat, Pakistan
MA KHAN Shahina Jamil Teaching Hospital Abbottabad, Pakistan
N RIAZ Department of Medicine, Hayatabad Medical Complex, Peshawar, Pakistan
IH ANJUM Department of Surgery, Sahara Medical College, Narowal, Pakistan

DOI:

https://doi.org/10.54112/bcsrj.v2024i1.1469

Keywords:

Chronic liver disease, osteoporosis, body mass index, Child-Pugh score, bone mineral density.

Abstract

Chronic liver disease (CLD) is a significant health concern often associated with systemic complications, including osteoporosis. Early detection of osteoporosis in CLD patients is critical for preventing fractures and improving quality of life. Objective: To determine the frequency of osteoporosis in patients with chronic liver disease (CLD).Methods: This cross-sectional study was carried over six months, from May 2024 to November 2024, and included 80 patients with confirmed CLD. Participants aged 30 to 60 years were recruited from outpatient and inpatient settings. Dual-energy X-ray absorptiometry (DEXA) was used to measure bone mineral density (BMD), which was then classified into normal or osteoporosis categories based on T-scores. Demographic and clinical data were collected through structured evaluations. Results: Mean age was 46.15 ± 9.46 years. Among the cohort, 20 patients (25.0%) had osteoporosis. Osteoporosis was associated with increasing age (p = 0.001), female gender (p = 0.004), lower BMI (p = 0.0001) and Child-Pugh Class (p = 0.02).Conclusion: Osteoporosis is a prevalent complication in CLD, associated with older age, female gender, lower BMI, and advanced disease severity.

Downloads

Download data is not yet available.

References

James SL, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1789-858.

Varacallo MA, Fox EJ. Osteoporosis and its complications. Med Clin North Am. 2014;98(4):817-31

Varacallo MA, Fox EJ, Paul EM, Hassenbein SE, Warlow PM. Patients' response toward an automated orthopedic osteoporosis intervention program. Geriatr Orthop Surg Rehabil. 2013;4(3):89-98.

Varacallo M, Seaman TJ, Jandu JS, Pizzutillo P. StatPearls [Internet]. StatPearls Publishing; Treasure Island (FL), 2023.

Kanis JA, Johansson H, Harvey NC, McCloskey EV. A brief history of FRAX. Arch Osteoporos. 2018;13(1):118.

Walzak LC, Loken Thornton W. The role of illness burden in theory of mind performance among older adults. Exp Aging Res. 2018;44(5):427-42.

Majeed T, Para RA, Hassan S, Shah AH. Prevalence of Osteoporosis in Chronic Liver Disease (CLD) Patients in a Tertiary Care Hospital. Natl J Med Res. 2019;9(01):18-22.

Kamioka H, Saeki C, Oikawa T, Kinoshita A, Kanai T, Ueda K, et al. Low geriatric nutritional risk index is associated with osteoporosis and fracture risk in patients with chronic liver disease: a cross-sectional study. Gastroenterology. 2024;24(1):376.

Hidalgo DF, Boonpheng B, Sikandar S, Nasr L, Hidalgo J. Chronic liver disease and the risk of osteoporotic fractures: A meta-analysis. Cureus. 2020;12(9):e10483

Jurado S, Parés A, Peris P, Combalia A, Monegal A, Guañabens N. Bilirubin increases viability and decreases osteoclast apoptosis contributing to osteoporosis in advanced liver diseases. Bone. 2022;162:116483.

Jadzic J, Djonic D. Bone loss in chronic liver diseases: Could healthy liver be a requirement for good bone health?. World J Gastroenterol. 2023;29(5):825.

Javed M, Saeed A, Khan IM, Hameed K, Rehman S, Khattak AK, Ahmad I, Khan SA. Frequency of osteoporosis in patients with cirrhosis due to hepatitis B and hepatitis C. J Ayub Med Coll Abbottabad. 2009;21(3):51-53.

Ninkovic M, Love SA, Tom B, Alexander GJ, Compston JE.. High prevalence of osteoporosis in patients with chronic liver disease prior to liver transplantation. Calcif Tissue Int. 2001;69:321.

Wariaghli G, Mounach A, Achemlal L, Benbaghdadi I, Aouragh A, Bezza A, El Maghraoui A. Osteoporosis in chronic liver disease: a case–control study. Rheumatol Int. 2010;30(7):893-9.

Yadav A, Carey EJ. Osteoporosis in chronic liver disease. Nutr Clin Pract. 2013;28(1):52-64.

Ahmed A, et al. Osteoporosis in chronic liver disease. Pak Armed Forces Med J. 2018;68(4):846–849.